Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 3/20 | 0.37 |
| ▸ | KDM4A | O75164 | 2/20 | 0.37 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.37 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.37 |
| ▸ | TET3 | O43151 | 1/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.37 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.37 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | LDHA | P00338 | 1/20 | 0.32 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.32 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.32 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL986002 | 0.86 | LTA4H (0.36) | TET2KDM4AKDM4CKDM2ATET3 | |
| SCHEMBL740658 | 0.82 | MAOA (0.39) | FOLH1PTPN1 | |
| SCHEMBL22043852 | 0.81 | ALDH1A1 (0.43) | TET2KDM4AKDM4CKDM2ATET3 | |
| SCHEMBL345432 | 0.78 | FOLH1 (0.31) | TET2KDM4AKDM4CKDM2ATET3 | |
| SCHEMBL288760 | 0.78 | ALDH1A1 (0.40) | KDM4AKDM4CKDM2AFOLH1LMNA | |
| SCHEMBL12148603 | 0.78 | CA1 (0.34) | TET2KDM4AKDM4CKDM2ATET3 | |
| SCHEMBL29233059 | 0.78 | GABRP (0.39) | LMNAMAPTCA1CA2 | |
| SCHEMBL10988936 | 0.78 | LMNA (0.44) | LMNASLC22A6LDHASRRALKBH5 | |
| SCHEMBL163217 | 0.78 | LMNA (0.44) | LMNASLC22A6LDHASRRALKBH5 | |
| SCHEMBL11037954 | 0.78 | TSHR (0.36) | TET2KDM4AKDM4CKDM2ATET3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7732382-B2 | Cross-linking composition and method of use | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-08 | — | — | US | claimed |
| CN-101421372-A | Crosslinking compositions and methods of use thereof | DU PONT (US) | 2009-04-29 | — | — | CN | claimed |
| WO-2007095367-A2 | CROSS-LINKING COMPOSITION AND METHOD OF USE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-08-23 | — | — | WO | claimed |
| US-20070187102-A1 | Hydraulic fracturing methods using cross-linking composition comprising delay agent | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-08-16 | — | — | US | claimed |
| US-20070191233-A1 | Cross-linking composition and method of use | DORF KETAL SPECIALITY CATALYSTS, LLC | 2007-08-16 | — | — | US | claimed |
| US-20070187642-A1 | Zirconium cross-linking composition and methods of use | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-08-16 | — | — | US | claimed |
| EP-3597670-B1 | WATER-SOLUBLE COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT THEREOF, AND CURED PRODUCT THEREOF, AND ACYL PHOSPHINATE | ADEKA CORP (JP) | 2024-07-10 | — | — | EP | disclosed |
| CN-110036343-B | Water-soluble composition, pattern forming agent, method for producing cured product using same, and cured product | 株式会社ADEKA | 2023-06-13 | — | — | CN | disclosed |
| US-11649334-B2 | Water-soluble composition, production method for cured product thereof, and cured product thereof, and acyl phosphinate | ADEKA CORPORATION (JP) | 2023-05-16 | — | — | US | disclosed |
| CN-110337454-B | Water-soluble composition, method for producing cured product thereof, and acylphosphinate | 株式会社ADEKA | 2022-04-12 | — | — | CN | disclosed |
| CN-109312135-B | Water-soluble composition and cured product comprising same | 株式会社ADEKA | 2021-07-06 | — | — | CN | disclosed |
| CN-112384538-A | Polymer, composition containing same, method for curing same, cured product thereof, and method for producing polymer | 株式会社ADEKA | 2021-02-19 | — | — | CN | disclosed |
| US-20200123371-A1 | WATER-SOLUBLE COMPOSITION AND CURED PRODUCT THEREOF | ADEKA CORPORATION (JP) | 2020-04-23 | — | — | US | disclosed |
| US-20070187098-A1 | Permeable zone and leak plugging using cross-linking composition comprising delay agent | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-08-16 | — | — | US | disclosed |
| US-20070187102-A1 | Hydraulic fracturing methods using cross-linking composition comprising delay agent | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-08-16 | — | — | US | disclosed |
| US-20070191236-A1 | cross-linking composition bistriethanolamine zirconate or tetra-triethanolamine zirconate, N,N,N',N'-tetrakis-(hydroxyisopropyl)ethylenediamine, cross-linkable polymer, water, and polyol; oil fields, hydraulic fracturing and plugging of permeable zones of subterranean formations; well bores | DORF KETAL SPECIALITY CATALYSTS, LLC | 2007-08-16 | — | — | US | disclosed |
| US-20070187642-A1 | Zirconium cross-linking composition and methods of use | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-08-16 | — | — | US | disclosed |
| US-20070191233-A1 | Cross-linking composition and method of use | DORF KETAL SPECIALITY CATALYSTS, LLC | 2007-08-16 | — | — | US | disclosed |
| CN-1606606-A | Water-base composition and crosslinking agent for water-soluble polymers | MATSUMOTO CHEMICAL INDUSTRY CO (JP) | 2005-04-13 | — | — | CN | disclosed |
| US-20050043454-A1 | Water-base composition and crosslinking agent for water-soluble polymers | MATSUMOTO CHEMICAL INDUSTRY CO. LTD. (JP) | 2005-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11649334-B2 | Water-soluble composition, production method for cured product thereof, and cured product thereof, and acyl phosphinate | PHOSPHO1, ASS1, SGMS1 | TET2 2670/4885KDM4A 1292/4885KDM4C 1309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.